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Conclusion: Reduced BMD and minimal trauma 
fractures are both features of HIES, but the degree 
of osteopenia does not correlate with fractures, 
nor is there Laboratory evidence of increased bone 
turnover. 
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HIV Treatment Induced 
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Variable Immune Deficiency (CVlD) 
O. Tsoukas*. McGill University Health Centre 
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Ave., Room A5-140 Montreal, Quebec H3G 1A4, 
Canada 
Background: OVID is a very heterogeneous syn- 
drome that is characterized by tow immunogtobutin 
production, impaired specific antibody responses 
to pathogens, recurrent bacterial infections, au- 
toimmune abnormalities and sptenomegaty. Causes 
for OVID include: failure of B celt maturation, aL- 
tered somatic hypermutation, defective celt mem- 
brane signaling, T celt abnormalities, reduced OD40 
tigand expression, inducible co-stimuLator protein 
(IOOS), and L-setectin and defects in tumor necro- 
sis factor receptor super family members. HIV in- 
fection induces abnormalities intrinsic to B ceLLs 
including hypergammagtobutinemia, increases au- 
toantibody LeveLs, activation markers and risk for 
B celt tymphoma. Despite the potyctonat hyper- 
gammagtobutenemia, paradoxicaLLy HIV infection 
results in poor specific antibody responsiveness to 
vaccination. In the world Literature, 4 patients with 
CVID have been reported that have had a reversal 
of hypogammagtobutinemia and improved antibody 
production as a result of HIV infection. We describe 
a fifth such patient whose antibody production was 
normal while infected with HIV yet declined as a 
result of antiretrovirat herapy (ART). 
Objective: To describe how HIV therapy unmasked 
hypogammagtobutinemia n this patient with HIV 
and OVID. 
Method: The Immune Deficiency Treatment Centre 
(IDTO) actively foLLows more than 700 persons with 
HIV and 45 with OVID. One person has both HIV 
and OVID. ParadoxicaLLy the patient was welt and 
asymptomatic prior to beginning potent ART. Within 
2 weeks of beginning treatment, his immunogtob- 
utin LeveLs felt dramaticaLLy and he developed bac- 
teria[ pneumonia and diarrhea. 
Results: In addition to tow immunogtobutin serum 
LeveLs, the patient had a B celt phenotype consis- 
tent with almost no memory B ceLLs. The impact of 
HIV therapy is shown in the table. 
Treatment NONE ART 
IVIG 
Date 04/2004 08/2004 06/2005 07/2005 09/2005 12/2005 
HIV-1 RNAcopies/m[ 111,000 107,800 175,000 976 <50 <50 
CD4 ce[[s/mm 3 407 290 100 130 96 225 
IgG (range 7-18g/L) 7.20 5.26 3.92 8.98 8.90 
IgA (range 0.7-5.0g/L) 1.10 1.10 0.51 0.53 0.53 
IgM (range 0.4-2.4g/L) 0.55 0.55 <0.24 <0.24  <0.24 
Conclusion: Understanding the recovery of anti- 
body production in a patient with CVID as a result 
of HIV infection, or the toss of immunogtobutin 
production in HIV infected patients with CVID who 
begin ART, may Lead to the identification of factors 
important in the pathogenesis of CVID. Studies of 
viral and immune factors in this patient are being 
initiated. 
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Background: Congenital hypothyroidism is caused 
by deveLopmentaL defects of the thyroid gland. 
Associated neuroLogicaL symptoms are due to the 
Lack of thyroid hormone in the developing brain. 
Here, we report a 34-year-oLd Caucasian woman 
with recurrent bronchitis, a LifeLong history of 
"cLumsiness" and "ataxia" without cognitive de- 
veLopmentaL delay. She had been diagnosed with 
hypothyroidism, and had been variously character- 
ized as having trunca[ ataxia, myoctonic dystonia, 
and factitious movement disorder. Previous evaLua- 
tion had shown a miLdLy diminished IgA (60% of the 
Lower Limit of normaL), but normal IgG and IgM. IgE 
was not elevated. 
History: The family history was remarkable. Her 
paternal grandfather had had "ataxia" and mild 
speech delay. Her father had had "cLumsiness" 
starting in childhood with a right foot drop. Her 
39-year-oLd brother was oxygen dependent due to 
severe pulmonary fibrosis, recurrent pneumonias 
and a similar neuroLogicaL disorder. Her frater- 
nal twin sister had a similar early onset neuro- 
Logical disorder and died of staphyLococcaL sepsis 
foLLowing Caesarean section delivery of a baby 
girL. The daughter of her deceased sister had the 
same neuroLogicaL disorder with onset in infancy. 
At[ affected adults had hypothyroidism and tow 
IgA LeveLs, similar to the index patient. In view 
of the famiLiaL consteLLation of neurotogic disor- 
der, hypothyroidism, and pulmonary fibrosis, we 
Looked for mutations in thyroid transcription fac- 
tor 1 (TTF-1, TITF1, Nkx2.1). TTF1 is an epitheLiaL 
